RGH‑4417 is a synthetic derivative of vinpocetine investigated for neuroprotective and cognitive-enhancing effects. It has been studied in the treatment of vascular dementia, memory disorders, and cerebral circulatory insufficiency. The compound improves cerebral blood flow and may enhance neuronal metabolism. It’s mainly used in research and is not widely approved for clinical use. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Dehydrovinpocetine Trimethoxybenzoate and RefChem:179063. Its PubChem CID is 174180.
Rgh 4417
| CAS No | 79720-73-3 |
|---|---|
| Molecular Formula | C30H34N2O5 |
| Molecular Weight | 502.6 g/mol |
| Synonyms | [(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]methyl 3,4,5-trimethoxybenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
RGH‑4417 is a synthetic derivative of vinpocetine investigated for neuroprotective and cognitive-enhancing effects. It has been studied in the treatment of vascular dementia, memory disorders, and cerebral circulatory insufficiency.
The listed CAS number is 79720-73-3.
The listed molecular formula is C30H34N2O5.
The listed molecular weight is 502.6 g/mol.
[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]methyl 3,4,5-trimethoxybenzoate.
The source lists Dehydrovinpocetine Trimethoxybenzoate and RefChem:179063.